Please note: You’ll get an immediate assessment when you request PBS authorities online.
Patient eligibility
The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with azacitidine under the National Health Act 1953, section 100 and subsidises treatment with decitabine+cedazuridine under the National Health Act 1953, section 85 for patients with CMML.
Patients must be eligible for the PBS and meet the relevant restriction criteria.
The Schedule of Pharmaceutical Benefits on the PBS website outlines the restrictions for prescribing azacitidine and decitabine+cedazuridine.
Section 100 arrangements
Azacitidine
This item is only PBS-subsidised for non-admitted patients, day admitted patients or patients on discharge who are attending:
- an approved private hospital
- a public participating hospital
- a public hospital.
This item isn’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.
Authority applications
Applying for initial treatment
Applications for initial authority approval to prescribe PBS-subsidised azacitidine to treat CMML can be made either in:
- real time using the Online PBS Authorities system
- writing and use HPOS Form upload
- writing and mail to PBS Complex Drugs Programs.
All written applications must include the completed:
- authority prescription form or forms
- chronic myelomonocytic leukaemia - azacitidine - initial authority application form
- relevant attachments.
Applications for initial authority approval to prescribe PBS-subsidised decitabine+cedazuridine to treat CMML can be made either in:
- real time using the Online PBS Authorities system
- writing and use HPOS Form upload
- writing and mail to PBS authority approvals.
All written applications must include the completed:
- authority prescription form or forms
- chronic myelomonocytic leukaemia - azacitidine - initial authority application form
- relevant attachments.
Applying for continuing treatment
Applications for continuing authority approval to prescribe PBS-subsidised azacitidine to treat CMML can be made either:
- in real time using the Online PBS Authorities system
- by calling the PBS Complex Drug Programs enquiry line.
Applications for continuing authority approval to prescribe PBS-subsidised decitabine+cedazuridine to treat CMML can be made either:
- in real time using the Online PBS Authorities system
- by calling the PBS authority approvals enquiry line.
More information
Call the PBS Complex Drugs Programs enquiry line for more information on azacitidine.
Call the PBS Authority Approvals enquiry line for more information on decitabine+cedazuridine.